Combining Immunotherapy and Targeted Therapy to Treat Melanoma
The FDA has approved a combination of the immune checkpoint inhibitor atezolizumab with two targeted therapies for certain patients with advanced melanoma.
Progress Against Cancer
The FDA has approved a combination of the immune checkpoint inhibitor atezolizumab with two targeted therapies for certain patients with advanced melanoma.
People who have been diagnosed with cancer are more likely than those without a cancer history to adhere to measures like wearing masks and avoiding crowded areas, and CAR-T cell therapy is becoming an option for treating more types of cancer.
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and that approximately 32 percent of patients will die within five years of diagnosis. However, the distribution of cancer and cancer-related deaths varies substantially across racial/ethnic groups.
The FDA has approved a CAR T-cell immunotherapy to treat certain adult patients with mantle cell lymphoma.
What happens if your workplace reopens before you’re ready to return or you’re an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.
The AACR Virtual Meeting: COVID-19 and Cancer opened Monday with a keynote address from the nation’s leading infectious disease expert, Anthony Fauci, MD, the director of the National Institutes of Allergy and Infectious Diseases. Well known for several decades in the realm of infectious diseases, Fauci has now become a household name in the United States due to his contributions in the response to the COVID-19 pandemic.
A clinical trial suggests that some people with breast cancer may be able to receive radiation therapy over fewer sessions and other cancer research news of the week from Cancer Today magazine.
People with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds.
Proposed changes to lung cancer screening guidelines would double the number of people eligible for yearly CT scans, and more news of the week from Cancer Today.
Health information tailored to ethnic subgroups or age group may be beneficial, according to a study in the AACR journal Cancer Epidemiology, Biomarkers & Prevention.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More